Research Hub Banner

    Select a Company

    Me Cure Industries Plc

    Health Care Pharmaceuticals & Biotechnology
    11.10 NGN     0 / 0%
    As of 16-Jun-2025

    Prev. Close

    11.10

    Volume

    257,145

    Turnover

    NGN 2,651,440.05

    Deals

    34

    Shares Outstanding

    4,000.00 mln

    Market Cap.

    NGN 44,400.00 mln


    Loading Chart ...


    52W RANGE

    7.35 - 13.90

    1W

    --

    1M

    --

    3M

    -1.33%

    YTD

    -20.14%

    1Y

    +15.99%


    loading...

    About the company

    Me Cure is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. For more than a decade, the company has tapped the power of new technology and innovation to advance the practice of medicine. Products: OTC Medicines, Branded Generics and Dietary Supplements.


    Website
    www.mecure.com
    info@mecure.com


    SYMBOL
    MECURE    		 ISIN
    NGMECURE0006
    Founded
    2005    		 Listed
    2023
    Phone
    -    		 FAX
    -

    Me Cure House, Plot 6, Block H, Apapa Oshodi Expressway, Oshodi, Lagos. Nigeria

    Competitors

    Fidson Healthcare Plc42.10+9.64%
    Neimeth International Pharmaceuticals Plc3.50+2.34%
    Pharma-Deko Plc1.83--
    May & Baker Nigeria Plc15.40--
    Juli Plc10.30--

    MECURE | Declaration of dividend4 Mar. 2025
    MECURE | Notice of board meeting14 Feb. 2025
    MECURE | Notice of closed period6 Jan. 2025
    MECURE | Share dealing 8 Nov. 2024
    MECURE | Share dealing 8 Nov. 2024
    MECURE | Notice of board meeting23 Oct. 2024
    MECURE | Acquisition of ten Percent Equity Stake6 Oct. 2024
    MECURE | Notice of board meeting5 Aug. 2024
    MECURE | AGM resolutions8 Jul. 2024
    MECURE | Notice of annual general meeting6 Jun. 2024
    MECURE | Appointment of independent directors16 May. 2024
    MECURE | Correction of 2023 AFS29 Apr. 2024
    MECURE | Declaration of dividend6 Mar. 2024
    MECURE | Rescheduled of board meeting27 Feb. 2024
    MECURE | Notice of board meeting15 Feb. 2024

    Me Cure Industries lists on Nigerian Exchange, market cap jumps to N13bn9 Nov. 2023

    Research & Analysis

    NGX | Nigerian Exchange - Monthly Equities Report - January 2025 : Upbeat start to the year across global & local markets5 Feb. 2025
    NGX | Nigeria Telecoms outlook - Tariff hike portends stronger earnings for operators23 Jan. 2025
    NGX | Nigeria: 2025 Macroeconomic Outlook : Pressure to Plateau31 Dec. 2024
    NGX | Afrinvest Weekly Stock Recommendation - October 28, 202428 Oct. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - September 2024 : Global equities rally on monetary policy decision; Energy stocks improve sentiment in local equities9 Oct. 2024
    NGX | Nigerian Cement mid-year outlook - Public demand to boost topline amid cost pressures4 Oct. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - August 2024 : US Fed’s dovish signaling excites global markets; Cement sector drags local equities5 Sep. 2024
    NGX | Weekly Roundup and Stock Recommendations - August 26, 202426 Aug. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - July 2024 : Rate cut expectation drives rotation into small caps; bearish bias in local equities7 Aug. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - April 2024 : The bears dominate performance across markets9 May. 2024

    Annual & Financials Reports

    Annual Report 2023
    Annual Report 2022
    Annual Report 2021
    Annual Report 2020
    Annual Report 2019
    Annual Report 2018

     

    0.15 NGN3 Jul. 2024

    Login